Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MGTA

Magenta Therapeutics (MGTA) Stock Price, News & Analysis

Magenta Therapeutics logo

About Magenta Therapeutics Stock (NASDAQ:MGTA)

Advanced Chart

Key Stats

Today's Range
$0.68
$0.76
50-Day Range
$0.36
$0.76
52-Week Range
$0.32
$2.07
Volume
376,000 shs
Average Volume
848,835 shs
Market Capitalization
$42.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MGTA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Magenta Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

MGTA Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

MGTA Stock Analysis - Frequently Asked Questions

Magenta Therapeutics, Inc. (NASDAQ:MGTA) announced its earnings results on Thursday, November, 4th. The company reported ($0.15) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.17) by $0.02.

Magenta Therapeutics's stock split on the morning of Thursday, September 7th 2023.The 2-1 split was announced on Thursday, September 7th 2023. The newly minted shares were issued to shareholders after the closing bell on Thursday, September 7th 2023. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Magenta Therapeutics (MGTA) raised $100 million in an IPO on Thursday, June 21st 2018. The company issued 6,700,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, Goldman Sachs and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Magenta Therapeutics investors own include TherapeuticsMD (TXMD), Sorrento Therapeutics (SRNE), NIO (NIO), Oncobiologics (OTLK), VBI Vaccines (VBIV), Corbus Pharmaceuticals (CRBP) and Dynavax Technologies (DVAX).

Company Calendar

Last Earnings
11/04/2021
Today
7/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
NASDAQ:MGTA
Fax
N/A
Employees
67
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$76.46 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$1.23 per share
Price / Book
0.57

Miscellaneous

Free Float
51,456,000
Market Cap
$42.44 million
Optionable
Not Optionable
Beta
2.12
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:MGTA) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners